$Clovis Oncology (CLVS.US)$https://www.businesswire.com/news/home/20220331005384/en/Clovis-Oncology%E2%80%99s-Rubraca%C2%AE-Rucaparib-Significantly-Improves-Progression-Free-Survival-in-First-line-Maintenance-Treatment-in-Women-with-Ovarian-Cancer-Regardless-of-Their-Biomarker-Status-in-Phase-3-ATHENA-MONO-Trial
已翻译
![又一个成功的里程碑完成了!](https://ussnsimg.moomoo.com/moo-1649178388-71311754-iPhone-1-org.jpg/thumb)
1
1
$苏轩堂 (SXTC.US)$
Additionally, the company has until June 13, 2022, to regain compliance with Nasdaq's minimum bid requirement of $1.00 or above.
Additionally, the company has until June 13, 2022, to regain compliance with Nasdaq's minimum bid requirement of $1.00 or above.
1